Xconomy

AUGUST 30, 2019

jumped the presentation by a week, promising in a statement Monday that the data were very good, indeed. But in Paris, this cardiologist will be in a conference center, walking an audience through a slide deck packed with Phase 3 data for a new cholesterol-lowering drug, inclisiran. Inclisiran’s owner, the Medicines Co.,

Slides 80

Slides Conference Venture Capital Study 80

Both Sides of the Table

JUNE 3, 2010

Went on to present at TechCrunch 50. And the broader question of whether VC’s will continue to invest in the Twitter ecosystem. Discussion: Had a long chat about PicClick , a company founded by Ryan Sit in San Diego. Was senior in shaping the curriculum and teaching efforts at Kaplan & Princeton Review. LibreDigital.

Venture Capital 214

Venture Capital Startup Design S3 214

Xconomy

DECEMBER 21, 2016

After years of research, frustration, hype, and millions (sometimes hundreds of millions) of dollars invested, a drug program boils down to the clinical data—usually from big, late-stage studies—that can sometimes make or break a company. There were high profile successes in 2016.

Study 40

Study Report Research Invest 40

Tech Zulu Event

JUNE 28, 2012

The first-ever Silicon Beach Fest attracted more than 2,000 attendees from LA, San Francisco, San Diego, Santa Barbara, New York, Toronto, and London to celebrate LA startups and entertainment with panels, parties, pitch fests, hackathon, and beach games: volleyball, basketball and surfing lessons in Santa Monica and Venice on June 21-23, 2012.

Hollywood 67

Hollywood Technical Review Startup Rustic Canyon 67

Xconomy

AUGUST 1, 2016

Neither company provided any specifics beyond the announcement, though Biogen said it will present the data in detail at a future medical meeting. Overall, 14 companies overall are investing in SMA programs, compared to zero in 2000, according to data from Cure SMA.

Study 40

Study Research Statistics Help 40

Xconomy

AUGUST 5, 2016

That story and plenty more—including a bevy of gene therapy news, the latest on the Zika virus, and a long-awaited presentation from an embattled CEO—below: —Theranos CEO Elizabeth Holmes spoke at a conference for laboratory scientists this week in Philadelphia.

News 40

News Thousand Oaks Pricing Report 40

Xconomy

SEPTEMBER 6, 2019

In presenting clinical data from a Phase 3 study. If MedCo’s cholesterol-lowering drug inclisiran wins FDA approval, it will become the third entry in a new class of medicines that block a cholesterol-boosting protein called PCSK9. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 84

Pricing Class Study Marketing 84

SoCal Delicious

OCTOBER 8, 2012

Developments Blog. To order presentation-ready copies for distribution to your colleagues, clients or customers, use the Order Reprints tool at the bottom of any article or visit www.djreprints.com. MSN Money Investing. Downtown San Diego Condos. Investment Land For Sale. Investing Tools. Commercial.

Los Angeles 44

Los Angeles Software Review Technical Review Journal 44

Xconomy

NOVEMBER 11, 2016

The Phase 3 results will be presented at a future medical meeting. —A month after Cambridge, MA-based Merrimack Pharmaceuticals (NASDAQ: MACK ) restructured and its CEO resigned , Reuters reported that the company has hired investment bankers to explore a possible sale. —Parsippany, NJ-based Medicines Co.

Patents 87

Patents Study Pricing Technical Review 87